1. Home
  2. ALRN vs CCG Comparison

ALRN vs CCG Comparison

Compare ALRN & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRN
  • CCG
  • Stock Information
  • Founded
  • ALRN 2001
  • CCG 2014
  • Country
  • ALRN United States
  • CCG China
  • Employees
  • ALRN N/A
  • CCG N/A
  • Industry
  • ALRN Biotechnology: Pharmaceutical Preparations
  • CCG
  • Sector
  • ALRN Health Care
  • CCG
  • Exchange
  • ALRN Nasdaq
  • CCG Nasdaq
  • Market Cap
  • ALRN 76.9M
  • CCG 64.8M
  • IPO Year
  • ALRN 2017
  • CCG N/A
  • Fundamental
  • Price
  • ALRN $1.92
  • CCG $0.77
  • Analyst Decision
  • ALRN Strong Buy
  • CCG
  • Analyst Count
  • ALRN 1
  • CCG 0
  • Target Price
  • ALRN $19.00
  • CCG N/A
  • AVG Volume (30 Days)
  • ALRN 92.8K
  • CCG 154.6K
  • Earning Date
  • ALRN 11-14-2024
  • CCG 11-26-2024
  • Dividend Yield
  • ALRN N/A
  • CCG N/A
  • EPS Growth
  • ALRN N/A
  • CCG N/A
  • EPS
  • ALRN N/A
  • CCG N/A
  • Revenue
  • ALRN N/A
  • CCG $478,620,143.00
  • Revenue This Year
  • ALRN N/A
  • CCG $4.89
  • Revenue Next Year
  • ALRN N/A
  • CCG $2.74
  • P/E Ratio
  • ALRN N/A
  • CCG N/A
  • Revenue Growth
  • ALRN N/A
  • CCG 4.67
  • 52 Week Low
  • ALRN $1.61
  • CCG $0.56
  • 52 Week High
  • ALRN $7.42
  • CCG $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ALRN 29.69
  • CCG 38.55
  • Support Level
  • ALRN $1.85
  • CCG $0.81
  • Resistance Level
  • ALRN $2.38
  • CCG $0.90
  • Average True Range (ATR)
  • ALRN 0.30
  • CCG 0.06
  • MACD
  • ALRN -0.01
  • CCG -0.01
  • Stochastic Oscillator
  • ALRN 6.31
  • CCG 9.57

About ALRN Aileron Therapeutics Inc.

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.

About CCG Cheche Group Inc.

Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.

Share on Social Networks: